News & Events Year None202120202019201820172016201520142013201220112009 06/09/21 REGENXBIO to Participate in Upcoming Investor Conferences 05/14/21 REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at American Society of Gene and Cell Therapy's 24th Annual Meeting 05/06/21 REGENXBIO to Present at Upcoming Investor Conferences 05/05/21 REGENXBIO Reports First Quarter 2021 Financial Results and Operational Highlights 04/28/21 REGENXBIO to Host Conference Call on May 5 to Discuss First Quarter 2021 Financial Results and Recent Operational Highlights 04/27/21 REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting 04/21/21 REGENXBIO To Present at the Chardan 5th Annual Genetic Medicines Manufacturing Summit Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
